Adenosine in pancreatic cancer: Emerging combination therapies

EBioMedicine. 2019 Oct:48:20-21. doi: 10.1016/j.ebiom.2019.09.030. Epub 2019 Oct 4.

Authors

Susanne Roth¹, Thilo Hackert²

Affiliations

¹ Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
² Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: thilo.hackert@med.uni-heidelberg.de.

No abstract available

Keywords: Adenosine; Combination therapies; Pancreatic cancer.

Publication types

Letter

MeSH terms

Adenosine / administration & dosage
Adenosine / metabolism*
Animals
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Disease Models, Animal
Disease Susceptibility
Humans
Mice
Pancreatic Neoplasms / etiology
Pancreatic Neoplasms / metabolism*
Pancreatic Neoplasms / pathology
Pancreatic Neoplasms / therapy
Xenograft Model Antitumor Assays

Substances

Adenosine